Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Comp Physiol B ; 192(1): 15-25, 2022 01.
Article in English | MEDLINE | ID: mdl-34415387

ABSTRACT

Insect sulfakinins are pleiotropic neuropeptides with the homology to vertebrate gastrin/cholecystokinin peptide family. They have been identified in many insect species and affect different metabolic processes. They have a strong influence on feeding and digestion as well as on carbohydrate and lipid processing. Our study reveals that sulfakinins influence fatty acids composition in Zophobas atratus oenocytes and regulate insulin-like peptides (ILPs) level in these cells. Oenocytes are cells responsible for maintenance of the body homeostasis and have an important role in the regulation of intermediary metabolism, especially of lipids. To analyze the lipid composition in oenocytes after sulfakinins injections we used gas chromatography combined with mass spectrometry and for ILPs level determination an immunoenzymatic test was used. Because sulfakinin peptides and their receptors are the main components of sulfakinin signaling, we also analyzed the presence of sulfakinin receptor transcript (SKR2) in insect tissues. We have identified for the first time the sulfakinin receptor transcript (SKR2) in insect oenocytes and found its distribution more widespread in the peripheral tissues (gut, fat body and haemolymph) as well as in the nervous and neuro-endocrine systems (brain, ventral nerve cord, corpora cardiaca/corpora allata CC/CA) of Z. atratus larvae. The presence of sulfakinin receptor transcript (SKR2) in oenocytes suggests that observed effects on oenocytes lipid and ILPs content may result from direction action of these peptides on oenocytes.


Subject(s)
Coleoptera , Insulins , Neuropeptides , Animals , Coleoptera/metabolism , Fatty Acids/metabolism , Insulins/metabolism , Larva/metabolism , Neuropeptides/metabolism
2.
Homo ; 68(1): 42-50, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28024658

ABSTRACT

In recent years, more scholarly attention has been paid to a growing range of geographic characteristics as antecedents of inequalities in women's health and well-being. The purpose of this study was to evaluate differences in health-related quality of life between rural and urban Polish postmenopausal women. Using a data set from a reproductive health preventive screening of 660 postmenopausal women aged 48-60 years, inhabitants of Wielkopolska and Lublin provinces, the association of place of residence, socioeconomic status and lifestyle factors with health-related quality of life (the SF-36 instrument) was evaluated using ANCOVA models and multiple logistic regression analysis with backward elimination steps. A consistent rural-to-urban gradient was found in all indices of physical health functioning and well-being but not in vitality, social functioning, emotional role and mental health scales with women in large cities being likely to enjoy the highest and those in villages the lowest quality of life. The rural-urban disparities in health-related quality of life were mediated by women's socioeconomic status. The likelihood of worse physical and mental functioning and well-being was 2-3 times greater for the low socioeconomic status rural women than their counterparts from more affluent urban areas. The educational attainment and employment status were the most powerful independent risk factors for health-related quality of life in both rural and urban women. Better understanding of the role of socioeconomic status that acts as a mediator in the association between area of residence and health-related quality of life may be useful in developing public health policies on health inequalities among women at midlife.


Subject(s)
Health Status Disparities , Postmenopause/physiology , Postmenopause/psychology , Rural Health , Urban Health , Cross-Sectional Studies , Female , Humans , Life Style , Middle Aged , Poland , Quality of Life , Risk Factors , Rural Population , Social Class , Surveys and Questionnaires , Urban Population
3.
Eur J Gynaecol Oncol ; 32(4): 393-8, 2011.
Article in English | MEDLINE | ID: mdl-21941959

ABSTRACT

Human papillomaviruses (HPV16, HPV18, HPV31, HPV33) are etiological agents in the development of cervical cancer. HPVs infect epithelial cells and depend on epithelial differentiation for the completion of their life cycle. Insulin-like growth factor I (IGF-I) is a potent mitogen involved in the regulation of cell proliferation and apoptosis of many cell types including normal and transformed epithelial cells. Deregulation of IGF-I expression and action is linked to diverse pathologies including cancer. A polymorphism in the P1 promoter region of the IGF-I gene may directly influence its expression. Using the PCR-SSCP method and sequencing of DNA, we identified a single nucleotide polymorphism (SNP) at -383(C>T) position of promoter P1 of the IGF-I in 16% of the study HPV-positive women with precancerous and cancerous lesions. In vitro, we observed that the SNP at-383(C>T) site significantly increased the reporter gene expresion in the HepG2 cell line, but not in the HeLa cell line relative to the wild type promoter. It suggests that the studied SNP can change expression of the IGF-I gene in distinct ways in different types of tissues. Deregulation of expression of the IGF-I gene can affect normal epithelium development and in case of HPV infection can potentially disrupt the virus life cycle and stimulate its passage into the oncogenic life cycle or persistent viral infections. Therefore, we propose that SNP C>T at the -383 position of P1 promoter may be one of the helpful prognostic markers in the diagnosis of cervical cancer development of women with persistent infection in the ectocervical epithelium. We have not found any association between the polymorphism CA repeats in the promoter P1 region of the IGF-I gene and suceptibility to HPV infection and cervical cancer development. The (CA)19 allele was the most common in the study of this group of women.


Subject(s)
Insulin-Like Growth Factor I/genetics , Papillomaviridae/genetics , Polymorphism, Genetic , Precancerous Conditions/genetics , Uterine Cervical Neoplasms/genetics , Adult , Aged , DNA, Viral/analysis , Female , Humans , Insulin-Like Growth Factor I/metabolism , Middle Aged , Polymorphism, Restriction Fragment Length , Promoter Regions, Genetic
4.
J Pediatr Endocrinol Metab ; 19(5): 733-9, 2006 May.
Article in English | MEDLINE | ID: mdl-16789640

ABSTRACT

DNA obtained from the blood cells of 88 adolescent patients with short stature, with low blood serum IGF-I concentrations, normal growth hormone (GH) secretion and normal GH receptor (GHR) structure, was analyzed in the promoter region for the IGF-I gene. A total of 24 genetic variants was detected in the DNA of 13 patients. An attempt was also made to analyze the impact of identified mutations on DNA-protein interactions using EMSA.


Subject(s)
Body Height/genetics , Insulin-Like Growth Factor I/genetics , Promoter Regions, Genetic/genetics , 5' Untranslated Regions/genetics , Adolescent , Binding Sites , Child , DNA/genetics , DNA/isolation & purification , Exons/genetics , Female , Genetic Variation , Growth/genetics , Growth/physiology , HeLa Cells , Humans , Male , Transcription Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...